IDEX Corp (NYSE: IEX) CEO granted new stock options and RSUs

Q: What did IDEX (IEX) CEO Eric Ashleman report in this Form 4 filing?

Eric Ashleman reported grants of stock options and restricted stock units , not open-market trades. He received 38,165 options and 9,040 RSUs/common shares as compensation awards that vest over several years starting February 22, 2027.

Q: How many IDEX (IEX) stock options were granted to the CEO in this Form 4?

The CEO was granted 38,165 stock options in this transaction. These options vest in four substantially equal annual installments beginning on February 22, 2027 , subject to his continuous service at IDEX Corp through each vesting date.

Q: What is the size and structure of the IDEX (IEX) CEO’s restricted stock award?

Eric Ashleman received 9,040 shares of common stock , reported as restricted stock units. Each RSU converts into one share and will vest in three substantially equal annual installments starting on February 22, 2027 , assuming continued service with IDEX.

Q: Are the IDEX (IEX) CEO’s Form 4 transactions open-market purchases or compensation grants?

The transactions are compensation grants , not market purchases. Both the 38,165 options and 9,040 RSUs/common shares were awarded at a stated price of $0.00 per share as part of his equity compensation package, subject to future vesting.

Q: When do the IDEX (IEX) CEO’s new RSUs and options begin vesting?

Both awards start vesting on February 22, 2027 . The RSUs vest in three substantially equal annual installments, while the stock options vest in four substantially equal annual installments, each contingent on continuous service through the relevant dates.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ASHLEMAN ERIC D reported acquisition or exercise transactions in this Form 4 filing.

IDEX CORP CEO and President Eric D. Ashleman reported equity awards rather than open-market trades. He received 38,165 options to buy IDEX common stock and a separate grant of 9,040 shares of common stock, awarded at a stated price of $0.00 per share as compensation.

The 9,040-share award represents restricted stock units, each convertible into one share of common stock. These RSUs vest in three substantially equal annual installments beginning February 22, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to continued service.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider ASHLEMAN ERIC D

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	OPTIONS (RIGHT TO BUY)	38,165	$0.00	--
Grant/Award	COMMON STOCK	9,040	$0.00	--

Holdings After Transaction: OPTIONS (RIGHT TO BUY) — 38,165 shares (Direct); COMMON STOCK — 66,658 shares (Direct)

Footnotes (1)

Represents an award of restricted stock units (?RSUs?). Each RSU represents a contingent right to receive one share of the Issuer?s common stock. These RSUs vest in three substantially equal annual installments beginning February 22, 2027, subject to the Reporting Person's continuous service through each such date. This option will vest in four substantially equal annual installments beginning February 22, 2027, subject to the Reporting Person's continuous service through each such date.

Form 4 Insider Transactions: What Each Field Means →

02/23/2026 - 09:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ASHLEMAN ERIC D

(Last)

(First)

(Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK

60062

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
02/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
COMMON STOCK	02/22/2026		A		9,040⁽¹⁾	A	$0	66,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
OPTIONS (RIGHT TO BUY)	$207.48	02/22/2026		A		38,165		⁽²⁾	02/22/2036	COMMON STOCK	38,165	$0	38,165	D

Explanation of Responses:

1. Represents an award of restricted stock units (?RSUs?). Each RSU represents a contingent right to receive one share of the Issuer?s common stock. These RSUs vest in three substantially equal annual installments beginning February 22, 2027, subject to the Reporting Person's continuous service through each such date.

2. This option will vest in four substantially equal annual installments beginning February 22, 2027, subject to the Reporting Person's continuous service through each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Sam Rayburn, by Power of Attorney	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did IDEX (IEX) CEO Eric Ashleman report in this Form 4 filing?

Eric Ashleman reported grants of stock options and restricted stock units, not open-market trades. He received 38,165 options and 9,040 RSUs/common shares as compensation awards that vest over several years starting February 22, 2027.

How many IDEX (IEX) stock options were granted to the CEO in this Form 4?

The CEO was granted 38,165 stock options in this transaction. These options vest in four substantially equal annual installments beginning on February 22, 2027, subject to his continuous service at IDEX Corp through each vesting date.

What is the size and structure of the IDEX (IEX) CEO’s restricted stock award?

Eric Ashleman received 9,040 shares of common stock, reported as restricted stock units. Each RSU converts into one share and will vest in three substantially equal annual installments starting on February 22, 2027, assuming continued service with IDEX.

Are the IDEX (IEX) CEO’s Form 4 transactions open-market purchases or compensation grants?

The transactions are compensation grants, not market purchases. Both the 38,165 options and 9,040 RSUs/common shares were awarded at a stated price of $0.00 per share as part of his equity compensation package, subject to future vesting.

When do the IDEX (IEX) CEO’s new RSUs and options begin vesting?

Both awards start vesting on February 22, 2027. The RSUs vest in three substantially equal annual installments, while the stock options vest in four substantially equal annual installments, each contingent on continuous service through the relevant dates.